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Abstract
Background Gynecomastia is defined as the benign
enlargement of the male breast. Most studies on surgical
treatment of gynecomastia show only small series and lack
histopathology results. The aim of this study was to analyze
the surgical approach in the treatment of gynecomastia and
the related outcome over a 10-year period.
Patients and methods All patients undergoing surgical
gynecomastia corrections in our department between 1996
and 2006 were included for retrospective evaluation. The
data were analyzed for etiology, stage of gynecomastia,
surgical technique, complications, risk factors, and histo-
logical results.
Results A total of 100 patients with 160 operations were
included. Techniques included subcutaneous mastectomy
alone or with additional hand-assisted liposuction, isolated
liposuction, and formal breast reduction. Atypical histo-
logical findings were found in 3% of the patients (spindle-
cell hemangioendothelioma, papilloma). The surgical
revision rate among all patients was 7%. Body mass index
and a weight of the resected specimen higher than 40 g
were identified as significant risk factors for complications
(p \ 0.05).
Conclusions The treatment of gynecomastia requires an
individualized approach. Caution must be taken in per-
forming large resections, which are associated with
increased complication rates. Histological tissue analysis
should be routinely performed in all true gynecomastia
corrections, because histological results may reveal atypi-
cal cellular pathology.
Gynecomastia is defined as the benign glandular prolifer-
ation of the male breast causing enlargement and thus a
feminine appearance [1]. In some patients, especially in the
adolescent, gynecomastia may regress spontaneously [2].
In persistent cases, pain, galactorrhea, or cancer phobia and
other psychological effects, including embarrassment, may
lead to the necessity of treatment. Medical treatment may
be effective at an early stage in which glandular tissue still
proliferates [1]. However, with time, the tissue will become
increasingly fibrotic and thus fail to respond to medical
therapy [1]. In such cases the surgical therapy of gyneco-
mastia is commonly accepted as the standard treatment.
Surgical approaches are numerous and include the
removal of the excessive glandular tissue and skin by
subcutaneous mastectomy, breast reduction, liposuction, or
a combination of these techniques [3–9].
To date, male breast diseases, including gynecomastia,
are not treated by one speciality of surgeons alone, but by
general, visceral, thoracic, and plastic surgeons. The pres-
ent literature on gynecomastia reflects a variety of
approaches and describes multiple individual techniques.
Unfortunately, most studies have small patient numbers
and lack a standardized classification, etiology, and—
especially—histopathological findings. However, all these
aspects are necessary to improve accuracy in the appro-
priate choice of the surgical approach and to allow
comparison with results from other studies. The present
study was designed to provide systematic evaluation of the
results of a 10-year period in surgical treatment of
gynecomastia with special focus on techniques, complica-
tions, and outcome.
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Patients and methods
A retrospective analysis of all patients undergoing surgery
for gynecomastia between November 1996 and March
2006 was conducted at the Department of Plastic Surgery
at the University Hospital of Berne. The preoperative
grading was performed using the Simon classification for
gynecomastia [10]: grade I, minor breast enlargement
without skin redundancy; grade IIa, moderate breast
enlargement without skin redundancy, grade IIb, moderate
breast enlargement with minor skin redundancy; grade III,
severe breast enlargement with skin redundancy simulating
a female breast.
The clinical evaluation included the etiology and
categorization of true gynecomastia (hypertrophy of
stroma and glandular cells) into five groups: (1) idio-
pathic (including adolescence/pubertal type), (2)
endocrine type, (3) tumor-related type, (4) metabolic
type (e.g., cirrhosis, diabetes, starvation), and (5) drug-
induced type. Patients treated for pseudogynecomastia, a
condition in which male breast enlargement is caused by
adipose hypertrophy and obesity, were also included in
the study. Patients underwent ultrasound imaging of
enlarged breasts prior to surgery in all cases of unilateral
gynecomastia, in the presence of mastodynia, and in
cases where enlargement of the male breast had occurred
within a short period of time (less than 6 months). If an
endocrine etiology was suspected, the patient underwent
an endocrinological evaluation first, including measure-
ment of hormone serum levels. In these cases, surgery
was performed only after completion of the appropriate
medical therapy.
The operations performed included subcutaneous mas-
tectomy, subcutaneous mastectomy with additional
liposuction, breast reduction, and isolated liposuction. The
operation was performed with either local or general
anesthesia. Single shot antibiotic prophylaxis was admin-
istered routinely (Cefuroxine 1.5 g i.v.). The subcutaneous
mastectomy was performed using a semicircular-periareo-
lar inferior incision as described by Webster [11]. In the
presence of excessive skin, periareolar skin reduction was
performed with the Benelli pursestring technique [12],
which was performed in both grades IIb and III gyneco-
mastia. In those cases of grade III gynecomastia where a
pursestring did not reduce enough of the excessive skin, a
formal breast reduction with a circumareolar and vertical
incision including skin resection was performed. Medial-
ization of the nipple–areolar complex was performed if
necessary; a semicircular skin excision with de-epithelial-
ization was combined with mastopexia in cases of severe
ptosis. Additional liposuction was performed in patients in
whom excessive fat tissue would compromise the esthetic
results following open resection of the hypertrophic gland.
The exclusive use of liposuction was reserved for cases
with pseudogynecomastia in the absence of a palpable
hypertrophic gland. The resected specimens underwent
histological analysis. A drain was routinely placed in the
resulting epipectoral cavity and remained for 1–3 days until
the drainage volume decreased under 20 ml/24 h. All
patients received a compression dressing for 1–2 weeks
following the operation. The patients were seen in an early
(first 2 postoperative weeks) and a late follow-up visit. The
following data were analyzed: age, weight, height, medical
history, operating time, weight of resected specimens,
histological findings, complications, and recurrence.
All results are given as percentage of the patients, except
for analysis of the surgical procedures, which are expressed
as percentage of the total procedures. Statistical analysis of
the data was performed using a post-hoc t-test, Fisher’s
exact test, and v2 test using the G-Power1 version 2.1.2
software.
Results
Patient data
Between 1996 and 2006, a total of 160 operations were
performed in 100 patients. (unilateral, n = 40; bilateral,
n = 60). The mean patient age was 28.9 : 14 years (range:
13.2–75 years). The mean body mass index (BMI) was
24.98 : 14 kg/m2 (range: 17.6–39.1 kg/m2). Also of note,
38% of the patients were active smokers ([10 cigarettes/
day).
Preoperative grading according to the Simon classifi-
cation included patients with stage I (n = 3), stage IIa
(n = 42), stage IIb (n = 31), and stage III (n = 24)
gynecomastia (Fig. 1). The underlying cause included the
following types: idiopathic/adolescence (55%), pseudogy-
necomastia (16%), endocrine (10%), drug-induced (8%),
metabolic (6%), and tumor-related (5%).
Mastodynia was present in 46% of the patients preop-
eratively. Twenty-six percent of patients received
preoperative medical therapy (systemic antiestrogen,
tamoxifen therapy). The operation was carried out under
general anesthesia (80%, stages I–III) or with local anes-
thesia (20%, stages I–IIa).
Surgical procedures
The operative techniques (Table 1) included subcutaneous
mastectomy alone (n = 90 operations (56%), stages I–IIb),
subcutaneous mastectomy with additional liposuction
(n = 44 operations (28%), stages IIa–III), subcutaneous
mastectomy with mastopexy and medialization of nipple–
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areolar complex (n = 11 operations (7%), stage III), iso-
lated liposuction (n = 11 operations (7%), stage IIa–III),
and breast reduction (n = 4 operations (2%), stage IIb–III).
The mean operating time for subcutaneous mastectomy
with or without liposuction was 57.7 : 21 min (range:
20–110 min), and mean operating time for isolated lipo-
suction was 48 : 5 min (range: 45–75 min) (t-test, n.s.,
p [ 0.05). The mean weight of the resected specimen was
92 : 44 g (range: 9–480 g). The histological examination
showed true, fibrotic gynecomastia in 78% of the patients,
with ductal hyperplasia present in 36% of the patients. In
two patients, ductal hyperplasia was combined with mild
metaplasia and apocrine secretion. Pseudogynecomastia
with exclusive fat tissue hypertrophy was described in 17%
of the patients. In three patients (3%) histological analysis
revealed further pathology including hemangioma (n = 1),
breast papilloma (n = 1), and spindle cell hemangioendo-
thelioma (n = 1) (Fig. 2). The resection margins of the
hemangioendothelioma and papilloma specimen were
tumor-free, and no further intervention was necessary.
Complications
Complications requiring further conservative or operative
treatment occurred in a total of 31% of all patients treated.
The complications involved postoperative bleeding and
hematoma (n = 9), and seroma formation (n = 8) (Table 2).
Surgical revision became necessary in 7% of the patients,
and the others were successfully treated conservatively.
Complications were exclusively observed in preoperative
stages IIa–III but did not differ statistically within these
three Simon stages.
The weight of the resected specimen correlated signifi-
cantly with major complication rates (\40 g: 1% versus[40
g: 51%; p = 0.0158). Overweight patients with a BMI greater
than 25 kg/m2 had a significantly higher complication rate
(36% versus 14%; p = 0.0373) (Table 3). Complication rates
were not different in patients treated with subcutaneous
mastectomy alone or with additional liposuction (13.9%
versus 15%, Fisher’s exact test; p = 0.69). Complications in
patients who were active smokers did not differ significantly
from those in nonsmokers (21% versus 18%; p = 0.125).
Minor complications were observed in 14% of all
patients and included areolar epidermolysis (n = 7 patients),
prolonged hypesthesia of the nipple–areolar complex (n = 6
patients), and wound dehiscence/necrosis (n = 1 patient).
All these were treated conservatively. The majority of the
patients (70%) experienced reversible hypesthesia of the
nipples at the early postoperative control.
The mean follow up was 8.8 : 4.5 months (range: 27–
725 days). Figures 3, 4, 5 and 6 illustrate postoperative
results. No patients suffered from persisting mastodynia.
There was one recurrence of gynecomastia following
isolated subcutaneous mastectomy in a grade IIb gyneco-
mastia (adolescent type, normal endocrine status). The
residual breast tissue, which had regrown, was re-excised.
An objective analysis of the late complications revealed
minimal persistence of excessive soft tissue (dog ear
deformity) (n = 6 patients), hypertrophic scarring (n = 3
patients), and persisting nipple hypesthesia (n = 2 patients).
None of the late complications required corrective opera-
tive treatment.
Discussion
The surgical approach to the treatment of gynecomastia
shows a wide variation in the literature, reflecting the lack
of clear guidelines. Early publications focused on surgical
excision of the glandular tissue, whereas more recent
studies advocate the unique use of liposuction, emphasiz-
ing superior esthetic results and decreased complication
rates [6, 7, 13, 14]. This, however, bears the potential for
overlooking atypical pathological findings in the male
breast tissue. In view of the above incertitude, it appeared
necessary to evaluate the results of a large series in a
10-year experience at one center in which open surgical
excision and routine histological sampling was performed
routinely.
Fig. 1 Preoperative staging (Simon classification) in 100 patients
Table 1 Surgical techniques for the treatment of gynecomastia
Technique (n = 160 procedures)
Subcutaneous mastectomy alone 56%
Subcutaneous mastectomy with hand-assisted liposuction 28%
Subcutaneous mastectomy with medialization/mastopexy 7%
Liposuction alone 7%
Breast reduction/skin excision 2%
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Thus the major concern with the exclusive use of lipo-
suction is the lack of histopathological analysis of the
resected tissue. Even though it is technically possible to
submit tissue pieces from liposuction to a histopathological
analysis [14], this has been performed only rarely, and the
results are difficult to interpret due to tissue damage and
consistency. In our series, 3% of patients were diagnosed
as having atypical cellular findings: The spindle-cell
hemangioendothelioma describes a number of vascular
lesions that vary not only in their morphologic features but,
more important, in their biological behavior [15]. In the
recent WHO classification of mesenchymal tumors, he-
mangioendotheliomas are defined as vascular neoplasms of
‘‘intermediate’’ or ‘‘borderline’’ malignancy, and spindle-
Fig. 2 Histological analysis of
gynecomastia specimens. (HE-
stain, 1:100) Left: typical
pattern of true fibrous
gynecomastia with mild ductal
hyperplasia. Right: spindle-cell
hemangioendothelioma in
gynecomastia tissue
Table 2 Early major and minor
complications in 100 patients.
(*requiring surgical revision).
At total of 31 complications
occurred in 100 patients.
Stage IIa (n = 42) Stage IIb (n = 31) Stage III (n = 24) Total
Hematoma 2 5 2 9 (*4)
Seroma 4 1 3 8 (*3)
Epidermolysis 3 4 7
Nipple hypesthesia 2 3 1 6
Wound necrosis 1 1
Total 11/42 14/31 6/24 31/100
Table 3 Risk factors for
postoperative complications
Risk factors Complications p value
Subcutaneous mastectomy alone versus with liposuction 13.9% versus 15% 0.69
Smokers versus nonsmokers 21% versus 18% 0.125
Overweight versus lean (BMI [ 25 kg/m2) 36% versus 14% *0.0373
Resected weight [40 g versus \40 g 51% versus 2% *0.0158
Fig. 3 Left: 23-year-old
patient with idiopathic,
unilateral gynecomastia (stage
IIb). Right: 3 months following
subcutaneous mastectomy with
assisting liposuction
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cell hemangioendotheliomas are included in this category
[15].
Another histolopathologic finding in the present study
was a breast papilloma, which also requires surgical exci-
sion in the co-presence of atypical ductal hyperplasia due
to the increased rate of associated neoplasia [16]. Bilateral
atypical ductal hyperplasia in gynecomastia specimens has
been described by other authors [17]. Nevertheless, it is
important to emphasize, that there is no convincing evi-
dence linking gynecomastia with increased incidence of
male breast cancer [18]. In contrast to gynecomastia, male
breast cancer has a peak at 71 years, and it usually presents
as a painless lump or nipple retraction [18]. However, this
does not eliminate the need for a histological examination
of the resected tissue [19–23]. Voulliaume et al. report a
case in which a patient received liposuction for ‘‘gyneco-
mastia,’’ which later proved to be established male breast
cancer. They point out the problem of dissemination of
malignant cells into healthy tissue during the liposuction
procedure [19]. Other authors have also described that
breast enlargement in young men is not always benign
gynecomastia: malignant tumours such as breast carcinoma
may be present in the midst of florid gynecomastia, even in
a young patient [20]. DeBree et al. describe a 22-year-old
man initially diagnosed with unilateral gynecomastia, in
which histological analysis revealed an invasive ductal
carcinoma of the breast [21]. In a recent publication,
Staerkle et al. report on synchronous bilateral ductal car-
cinoma in situ in a young man presenting with bilateral
gynecomastia [22]. Wadie et al. describe a case of a 16-
year-old boy with bilateral gynecomastia, in which the
histological work-up revealed a ductal carcinoma in situ
[23].
Taken together, these data emphasize the need for a
histological analysis because gynecomastia may be har-
boring a neoplasia. Liposuction as an exclusive procedure
should be limited to cases of pure pseudogynecomastia, in
which preoperative assessment shows the presence of an
isolated lipohypertrophy with no sign of glandular
enlargement.
The classic semicircular-periareolar inferior incision
proved to be a valid access in grade I–IIb gynecomastia in
this study. Aslan et al. suggest a modified surgical access
that uses a W-shaped periareolar-transareolar-perithelial
incision to provide wide exposure of the resection area and
to facilitate nipple–areolar reduction in advanced stages
Fig. 4 Left: 21-year-old
patient with idiopathic, bilateral
gynecomastia mimicking
tubular breast deformity (stage
IIa). Right: 5 months following
subcutaneous mastectomy and
mastopexy
Fig. 5 Left: 20-year-old
patient with idiopathic, bilateral
gynecomastia (stage IIb).
Right: 6 months following
subcutaneous mastectomy with
assisted liposuction
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[24]. In cases with redundant skin (IIb–III), simultaneous
medialization and cranialization of the nipple–areola
complex completing the semicircular medial incision to a
periareolar de-epthelialzation were useful. Rarely, large
ptosis in grade III cases of gynecomastia may require
formal breast reduction with an I- or T-shaped pattern.
The most frequent complication of subcutaneous mas-
tectomy in the present study was postoperative bleeding
and hematoma or seroma formation. This finding is con-
sistent with the results of other series, which have
described an overall complication rate of up to 28% in all
patients [4, 8]. The statistically significant increase of
complications in resections exceeding 40 g of breast tissue
is of clinical consequence to the postoperative treatment.
The larger wound area and resection weight in overweight
patients (BMI [ 25 kg/m2) may explain the higher com-
plication rates in this group. Based on the analysis of our
retrospective data, we have now extended the duration of
the compressive dressing to a 3-week period following
surgery, especially in overweight patients and larger
resections.
To prevent hematoma and seroma formation, we advise
patients to refrain from physical activities for a period of 4–
6 weeks postoperatively. So far, we have observed no
further hematoma or seroma in these patients. In over-
weight patients and in cases of large resections, surgeons
should consider leaving compressive dressings beyond
hospital stay, thus maintaining prolonged wound
compression.
The use of additional liposuction may improve the
postoperative results, especially if the excision of an
enlarged gland results in a concave deformity of the rem-
nant breast. Some authors have even suggested the
exclusive use of liposuction in the surgical treatment of
Fig. 6 Left: 46-year-old
patient with bilateral
pseudogynecomastia (stage III).
Right: 12 months following
subcutaneous mastectomy and
mastopexy
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gynecomastia [6, 7, 13]. Hodgson et al. report on a small
series of 13 patients with gynecomastia treated exclusively
by ultrasonic liposuction [13]. They report no early post-
operative complications of hematoma, seroma, infection, or
thermal injuries, and they state that ‘‘ultrasound-assisted
liposuction can be attempted for all types of gynecomastia’’
[13]. In another study, 61 patients with grade I–III
gynecomastia were treated with liposuction only (suction-
assisted lipectomy and ultrasound-assisted liposuction) [7].
Although the authors describe no early postoperative
complications, 13% of the patients required a open excision
of remaining breast tissue and redundant skin 6–9 months
postoperatively [7].
In our study, unilateral gynecomastia was found in 40%
of the patients. In other large studies the incidence of
unilateral involvement varies from 14% to 51% [3, 8].
However, unilateral gynecomastia may not be as unique as
anticipated by some authors. Diagnostic reports describe
unilateral gynecomastia in about 40% of men who undergo
mammography [25] or high-frequency color Doppler
ultrasonography [26] for breast enlargement due to
gynecomastia.
In conclusion, the surgical treatment of gynecomastia
requires an individual approach, depending on the grade of
male breast hypertrophy. Based on the presented data, true
glandular hypertrophy requires a surgical glandular tissue
excision and subsequent histological examination, thus
avoiding oncological pitfalls. Liposuction can be used as an
additional technique for optimizing the esthetic result fol-
lowing the excision of the glandular tissue. Exclusive
liposuction should be restricted to cases of pseudogyne-
comastia. In larger resections and in overweight patients,
caution must be taken, because complications including
bleeding and hematoma formation may be increased. In
patients presenting with massive skin redundancy (grade
III), the treating surgeon should be experienced in breast
reduction techniques. The presented series indicate that
subcutaneous mastectomy with or without additional hand-
assisted liposuction provides an excellent outcome with
extremely low recurrence rates.
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